Log in
Enquire now
PrognomiQ

PrognomiQ

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

OverviewStructured DataIssuesContributors

Contents

prognomiq.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biotechnology
Biotechnology
Health technology
Health technology
Location
San Mateo, California
San Mateo, California
B2X
B2B
B2B
CEO
‌
Philip Ma
Founder
‌
Philip Ma
Pitchbook URL
pitchbook.com/profiles...443012-68
Legal Name
PrognomiQ, Inc.0
Number of Employees (Ranges)
11 – 50
Email Address
info@prognomiq.com0
Full Address
1900 Alameda de las Pulgas, Suite 100, San Mateo, CA 94403, United States0
Investors
Catalio Capital Management
Catalio Capital Management
Maverick Ventures
Maverick Ventures
Wing Venture Capital
Wing Venture Capital
Bruker
Bruker
Invus
Invus
T. Rowe Price
T. Rowe Price
Fidelity Investments
Fidelity Investments
...
Founded Date
2020
0
Total Funding Amount (USD)
80,000,000
Latest Funding Round Date
November 5, 2024
CTO
‌
Bruce Wilcox
Latest Funding Type
Series D
Series D
Patents Assigned (Count)
1

Other attributes

Latest Funding Round Amount (USD)
34,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like PrognomiQ

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.